Bitdefender vs Kaspersky (2024): Which solution is better?

Cybersecurity threats have become one of the biggest concerns for companies of all sizes. These security threats are often more…

Gilead PrEP lenacapavir succeeds in phase 3 trial

The logo of the pharmaceutical company Gilead Sciences in Oceanside, California, on April 29, 2020. Mike Blake | Reuters GileadThe…